Structure-activity relationship studies of the tricyclic indoline resistance-modifying agent.

Le Chang,Jessica D Podoll,Wei Wang,Shane Walls,Courtney P O'Rourke,Xiang Wang
DOI: https://doi.org/10.1021/jm500146g
IF: 8.039
2014-01-01
Journal of Medicinal Chemistry
Abstract:Previously we discovered a tricyclic indoline, N-[2-(6-bromo-4-methylidene-2,3,4,4a,9,9a-hexahydro-1H-carbazol-4a-yl)ethyl] -4-chlorobenzene-1-sulfonamide (1, Ofl), from bioinspired synthesis of a highly diverse polycyclic indoline alkaloid library, that selectively resensitizes methicillin-resistant Staphylococcus aureus strains to beta-lactam antibiotics. Herein, we report a thorough structure-activity relationship investigation of 1, which identified regions of I that tolerate modifications without compromising activity and afforded the discovery of a more potent analogue with reduced mammalian toxicity.
What problem does this paper attempt to address?